News 4: San Antonio oncologist breaks down new mammogram screening guidelines
Kate Lathrop, MD, Hematology & Oncology, UT Health San Antonio Mays Cancer Center, was interviewed for this news segment. Watch Now
Share This Story
Category ID
171
Mays Cancer Center conducts only clinical trial in America of a specific drug combination for lethal brain cancer glioblastoma
An improvement in 6-month progression-free survival warrants additional study in a larger trial, researchers said. The Mays Cancer Center at The University of Texas Health Science Center at San Antonio recently conducted a clinical trial combining two drugs in patients with recurrent, high-grade glioblastoma (GBM). The Mays Cancer Center, one of the four National Cancer […]
Share This Story
Molecule shows potential to combat treatment resistance in brain tumor glioblastoma
Glioblastoma-impacted mice lived longer when treated with combination of molecule drug and chemotherapy agent Glioblastoma (GBM), a highly devastating brain tumor, has long posed challenges as effective treatments have remained elusive. Despite responding initially to treatment, GBM patients often experience therapy resistance leading to low long-term survival rates, with only 7.2% of patients surviving beyond […]
Share This Story
KENS 5: New recommendations in place for breast cancer screenings
Virginia Kaklamani, MD, Medicine, Hematology & Oncology, UT Health San Antonio Mays Cancer Center, was interviewed for this news segment about new recommendations for women receiving mammograms. Watch Now
Share This Story
KSAT 12 — Leading SA: UT Health San Antonio MD Anderson Medical Oncologist discusses breast cancer, mammogram screening guidelines
Virginia Kaklamani, MD, Medicine, Hematology & Oncology, UT Health San Antonio Mays Cancer Center, was interviewed for this news segment about new recommendations for women receiving mammograms. Watch Now
Share This Story